Jim Cramer: This Energy Stock Is A Buy, Stay Away From DexCom
Jim Cramer: This Energy Stock Is A Buy, Stay Away From DexCom
On CNBC's "Mad Money Lightning Round," Jim Cramer said Oneok (NYSE:OKE) is "terrific" and recommended buying more of the stock.
在CNBC的「瘋狂金錢閃電戰」上，吉姆·克雷默表示Oneok（紐交所：OKE）非常出色，建議購買更多股票。
On Aug. 5, ONEOK reported better-than-expected second-quarter GAAP EPS results, posting quarterly earnings of $1.33 per share which beat the analyst consensus estimate of $1.21 per share.
8月5日，ONEOk報告了超預期的第二季度GAAP每股收益結果，季度收益爲1.33美元，超過分析師共識預估的1.21美元每股收益。
"The problem with Dollar Tree (NASDAQ:DLTR) is that people I think have discovered that the small form is no longer working, they would rather go to Walmart (NYSE:WMT), which is a buy, or Costco (NASDAQ:COST) if they can afford the membership fee," he said.
他說：「美元樹（納斯達克：DLTR）的問題在於，人們發現小型形式不再起作用，他們寧願去沃爾瑪（紐交所：WMT），這是一款買入的股票，或者如果能負擔得起會員費，則去好市多（納斯達克：COST）。」
On July 16, Piper Sandler analyst Peter Keith downgraded the rating for Dollar Tree from Overweight to Neutral and lowered the price target from $143 to $112.
7月16日，派傑投資分析師彼得·基思將美元樹的評級從超重調降至中立，並將目標價從143美元下調至112美元。
The "Mad Money" host recommended staying away from Dexcom, Inc. (NASDAQ:DXCM). "Dexcom had a real bad miss. They still really haven't fully explained why that is," he noted.
「瘋狂金錢」主持人建議遠離德康醫療（納斯達克：DXCM）。「德康醫療錯失了真正的機會，他們仍然沒有充分解釋爲什麼，」他指出。
Dexcom specializes in selling continuous glucose monitors.
德康醫療專業銷售連續血糖監測儀。
On Aug. 5, Baird analyst Jeff Johnson downgraded the company from Outperform to Neutral and slashed the price target from $161 to $80.
8月5日，貝爾德分析師傑夫·約翰遜將該公司的評級從超越市場調整爲中立，並將目標價從161美元下調至80美元。
When asked about KeyCorp (NYSE:KEY), he said, "Definitely keep Key. Key is very, very strong, a terrific, terrific bank."
在談到KeyCorp（紐交所：KEY）時，他說：「絕對可以持有Key。Key銀行非常非常強大。」
Cramer said he would be a buyer of CRISPR Therapeutics AG (NASDAQ:CRSP).
克雷默表示他將成爲crispr therapeutics股份公司（納斯達克：CRSP）的買家。
On Aug. 5, CRISPR Therapeutics posted a narrower-than-expected quarterly loss.
8月5日，crispr therapeutics發佈了比預期略窄的季度虧損。
Price Action:
價格行動：
- Dollar Tree shares fell 1.6% to settle at $95.03 on Wednesday.
- Oneok shares rose 0.9% to close at $83.06.
- Dexcom shares fell 7.8% to close at $69.32.
- CRISPR shares fell 4.2% to settle at $47.27 on Wednesday.
- Palo Alto shares rose 2.6% to close at $301.93 on Tuesday.
- 美元樹股價下跌1.6％，收於95.03美元。
- Oneok股價上漲0.9％，收於83.06美元。
- 德康醫療股價下跌7.8％，收於69.32美元。
- CRISPR股價下跌4.2％，收於47.27美元。
- Palo Alto股價上漲2.6％，收於301.93美元。
- Wall Street's Most Accurate Analysts Give Their Take On 3 Consumer Stocks Delivering High-Dividend Yields
- 華爾街最準確的分析師對三隻消費股票的高股息收益率進行評估
譯文內容由第三人軟體翻譯。